Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Post by canadafanon Jan 05, 2024 1:38pm
331 Views
Post# 35812801

Corporate communications 101

Corporate communications 101

Hello all & happy 2024!

For mutiple reasons. ( family & personal health), I do hope 2024 is a better year.
On to Onc, afterall this is an Onc chat site.

Lots of discussions lately around trying to communicate & lack of feedback from Onc.
Including an aledged conversation regarding Andrew G departure & various USA office situations.
First I have been around the investment world since 1978. Being in the working business world since 1977.
Corporate disclosure regarding employees?
The employment or end of employment is considered personal & confidential.
Companies simply can not & will not disclose details. Exceptions? If there is already public knowledge ie various items in the news.
Even at that. When various public figures are let go for obvious reasons. That is usually glossed over, " he/ she & the company have reached a decision & he/ she is no longer with the company"
Details are confidential.

Regarding the office. A quick search does show  it to be up for lease, available Feb 1st.
Imho that information is relevant.

Now, in a NDA blackout, they can not even confirm or deny there is or is not a black out.
A very difficult position to be in, when everyone is demanding explanations.

Regarding sending emails & getting responses?
That is 100% depending on what questions you are asking.
They can not & will not disclose anything , being predictions , estimates etc etc.
That is not already in public knowledge via SEDAR or other type of media.
Meaning, just because you ask, does not allow them to break public disclosure rules.
Afterall, that would give the caller " insider information".

With the above mentioned personl health reasons, I have not given a lot of resd to the recent " update".
With any communication, one needs to understand context, what is said & most important what is not said.
My quick glance? It all could be derived from the corporate website. Either in the various categories or the pdf corporate presentation.
The N.R. Is/ was a summery of what is already known.
so, the mystery continues.
One thing iim certain of. There will be more updates & not too far off.
Could be as far off as Q4, yr end. I do doubt that howevr.
in the wait time. Lots & lots of confusion & doubt, creating an ultra low SP.
I had some loose change & bought some more today.
There is enough science & potential upside to validate the risk. IMHO



 

<< Previous
Bullboard Posts
Next >>